| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 150.639 | 162.913 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 150.639 | 162.913 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 17.106 | 130.758 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 133.533 | 32.155 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 112.168 | 26.916 |
| Employees | - | - | - | - | - | - | - | - | 1 | 4 |
Check the financial reports for the company - Biogen Labrom S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 0 | 96 |
| Current Assets | - | - | - | - | - | - | - | - | 157.008 | 207.763 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | - | 153.979 | 207.674 |
| Cash | - | - | - | - | - | - | - | - | 3.029 | 89 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 112.208 | 138.496 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 44.959 | 69.363 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
7120
|
|||||||||
Comments - Biogen Labrom S.r.l.